| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $32.1M | -55.8% |
| SG&A Expense | $41.0M | +24.7% |
| Operating Income | -$135.2M | -28.0% |
| Net Income | -$124.7M | -23.4% |
| EPS (Basic) | -$2.19 | -19.0% |
| EPS (Diluted) | -$2.19 | -19.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $184.3M | +286.0% |
| Current Assets | $188.0M | -31.7% |
| Total Assets | $188.5M | -41.5% |
| Current Liabilities | $4.8M | -63.2% |
| Total Liabilities | $4.9M | -81.0% |
| Stockholders' Equity | $183.6M | -38.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$90.0M | -2.3% |
| Capital Expenditures | $10.9M | +64.6% |
| Investing Cash Flow | $226.3M | +193.6% |
| Financing Cash Flow | $190K | -68.2% |
| Free Cash Flow | -$100.9M | -6.6% |